首页 / 院系成果 / 成果详情页

Immune dysregulation in myelodysplastic syndrome: Clinical features, pathogenesis and therapeutic strategies 期刊论文

编号：

4a1bca0c-ca16-458c-a62d-f2b2f7d745be
作者：

Wang, Cong(王聪)#^[1]Yang, Yan(杨岩)^[1]Gao, Sujun(高素君)^[1]Chen, Jingcheng^[1];Yu, Jinyuan^[2];Zhang, Han^[2];Li, Mingxi^[2];Zhan, Xingying^[2];Li, Wei(李薇)*^[1]
语种：

英文
期刊：

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY ISSN：1040-8428 2018 年 122 卷 (123 - 132) ; FEB
收录：
关键词：

Myelodysplastic syndromes Autoimmune diseases Immunosuppressive therapy Checkpoint inhibitors Hypomethylating agents
推荐引用方式
GB/T 7714：

Wang Cong,Yang Yan,Gao Sujun, et al. Immune dysregulation in myelodysplastic syndrome: Clinical features, pathogenesis and therapeutic strategies [J].CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY,2018,122:123-132.
APA：

Wang Cong,Yang Yan,Gao Sujun,Chen Jingcheng,&Li Wei.(2018).Immune dysregulation in myelodysplastic syndrome: Clinical features, pathogenesis and therapeutic strategies .CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY,122:123-132.
MLA：

Wang Cong, et al. "Immune dysregulation in myelodysplastic syndrome: Clinical features, pathogenesis and therapeutic strategies" .CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 122(2018):123-132.
条目包含文件：

文件类型：PDF,文件大小：

正在加载全文

未找到全文

浏览次数：74  下载次数：0

浏览次数：74

下载次数：0

打印次数：0